116 related articles for article (PubMed ID: 7543195)
1. IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR.
Kirchhoff S; Koromilas AE; Schaper F; Grashoff M; Sonenberg N; Hauser H
Oncogene; 1995 Aug; 11(3):439-45. PubMed ID: 7543195
[TBL] [Abstract][Full Text] [Related]
2. Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q- associated leukemias.
Beretta L; Gabbay M; Berger R; Hanash SM; Sonenberg N
Oncogene; 1996 Apr; 12(7):1593-6. PubMed ID: 8622878
[TBL] [Abstract][Full Text] [Related]
3. Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins.
Nguyen H; Lin R; Hiscott J
Oncogene; 1997 Sep; 15(12):1425-35. PubMed ID: 9333018
[TBL] [Abstract][Full Text] [Related]
4. The genes of interferons and interferon-related factors: localization and relationships with chromosome aberrations in cancer.
Haus O
Arch Immunol Ther Exp (Warsz); 2000; 48(2):95-100. PubMed ID: 10807049
[TBL] [Abstract][Full Text] [Related]
5. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
[TBL] [Abstract][Full Text] [Related]
6. Cooperative activity between HER oncogenes and the tumor suppressor IRF-1 results in apoptosis.
Kirchhoff S; Hauser H
Oncogene; 1999 Jun; 18(25):3725-36. PubMed ID: 10391680
[TBL] [Abstract][Full Text] [Related]
7. IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo.
Kröger A; Dallügge A; Kirchhoff S; Hauser H
Oncogene; 2003 Feb; 22(7):1045-56. PubMed ID: 12592391
[TBL] [Abstract][Full Text] [Related]
8. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.
Thornton AM; Ogryzko VV; Dent A; Sharf R; Levi BZ; Kanno Y; Staudt LM; Howard BH; Ozato K
J Immunol; 1996 Dec; 157(11):5145-54. PubMed ID: 8943426
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain.
Nguyen H; Mustafa A; Hiscott J; Lin R
Oncogene; 1995 Aug; 11(3):537-44. PubMed ID: 7630638
[TBL] [Abstract][Full Text] [Related]
10. [Interferon].
Tanaka H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1471-6. PubMed ID: 9309144
[TBL] [Abstract][Full Text] [Related]
11. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
12. IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice.
Yim JH; Wu SJ; Casey MJ; Norton JA; Doherty GM
J Immunol; 1997 Feb; 158(3):1284-92. PubMed ID: 9013971
[TBL] [Abstract][Full Text] [Related]
13. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors.
Gil J; Esteban M
Oncogene; 2000 Jul; 19(32):3665-74. PubMed ID: 10951573
[TBL] [Abstract][Full Text] [Related]
14. Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways.
Wong AH; Tam NW; Yang YL; Cuddihy AR; Li S; Kirchhoff S; Hauser H; Decker T; Koromilas AE
EMBO J; 1997 Mar; 16(6):1291-304. PubMed ID: 9135145
[TBL] [Abstract][Full Text] [Related]
15. The role of interferon regulatory factor-1 in cytokine-induced mRNA expression and cell death in murine pancreatic beta-cells.
Pavlovic D; Chen MC; Gysemans CA; Mathieu C; Eizirik DL
Eur Cytokine Netw; 1999 Sep; 10(3):403-12. PubMed ID: 10477397
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle regulation of the double stranded RNA activated protein kinase, PKR.
Zamanian-Daryoush M; Der SD; Williams BR
Oncogene; 1999 Jan; 18(2):315-26. PubMed ID: 9927188
[TBL] [Abstract][Full Text] [Related]
17. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
[TBL] [Abstract][Full Text] [Related]
18. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB.
Kumar A; Yang YL; Flati V; Der S; Kadereit S; Deb A; Haque J; Reis L; Weissmann C; Williams BR
EMBO J; 1997 Jan; 16(2):406-16. PubMed ID: 9029159
[TBL] [Abstract][Full Text] [Related]
19. The interferon system: a review with emphasis on the role of PKR in growth control.
Jaramillo ML; Abraham N; Bell JC
Cancer Invest; 1995; 13(3):327-38. PubMed ID: 7538039
[No Abstract] [Full Text] [Related]
20. Involvement of the double-stranded-RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity.
Der SD; Lau AS
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8841-5. PubMed ID: 7568028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
